207_Combined course Presentations

GOG-0249

• Phase III study of pelvic RT vs. vaginal BT + 3# carbo-Taxol chemotherapy

• High-intermediate risk factors (GOG-99) - G2 or 3, LVSI, deep myometrial invasion:

– Stage I, age ≥ 70, 1 risk factor – Stage I, age ≥ 50, 2 risk factors – Stage I, age ≥ 18, 3 risk factors – Stage II disease with or without risk factors

• Target accrual = 562